DISS, England--(BUSINESS WIRE)--Syne qua non (SQN), today announced a significant enhancement to their EDC and Clinical Trial Management System, Syne-clin®. A senior clinical research professional recently described Syne-clin® as delivering the ease of use and functionality that many envisaged EDC should have delivered when it was first introduced decades ago.
